Lu AG13909
- Generic Name
- Lu AG13909
A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 18
- Registration Number
- NCT06471829
- Locations
- π¬πͺ
Ltd Tbilisi Central Hospital, Tbilisi, Georgia
π¬πͺLtd Aversi Clinic, Tbilisi, Georgia
π«π·Assistance Publique Hopitaux de Marseille (AP-HM) - Hopital La Conception, Marseille, France
Study of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
- First Posted Date
- 2023-01-03
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 12
- Registration Number
- NCT05669950
- Locations
- π¬π§
University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
πΈπͺKarolinska University Hospital/ Huddinge, Huddinge, Sweden
πΈπͺSahlgrenska University Hospital, Gothenburg, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath